Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
IND Vs NZ 1st ODI: Virat 93, All-Round Harshit Secure Winning Start To 2026, Gill & Co Go 1-0 Up In Thrilling Clash
From Polluted River To Flooded Roads: Dahisar’s R-North Ward In Distress
VIDEO: Nandani Sharma CREATES History, Young Delhi Capitals Star Picks Up Hat-trick In 4-Wicket Final Over In WPL 2026
Mumbai BMC Elections 2026 Highlight Rising Female Leadership As Parties Field Women Across Reserved And Open Wards
(With inputs from PTI)
